Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2000
08/03/2000WO2000044907A1 Gene encoding flavone synthase
08/03/2000WO2000044906A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
08/03/2000WO2000044905A1 Slow growing acid-fast bacterium polypeptide
08/03/2000WO2000044904A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044902A2 Biomarkers and assays for carcinogenesis induced by phenobarbitol
08/03/2000WO2000044901A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044899A1 Her-2/neu fusion proteins
08/03/2000WO2000044898A2 Novel agouti and agouti-related peptide analogs
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044896A1 Internal ribosome entry site (ires), vector containing same and uses thereof
08/03/2000WO2000044895A1 Method and medicament for inhibiting the expression of a defined gene
08/03/2000WO2000044894A1 Method for isolating apoptosis-inducing dna sequences and detection system
08/03/2000WO2000044893A1 In vitro activated gamma delta lymphocytes
08/03/2000WO2000044891A1 Dna-containing ink
08/03/2000WO2000044889A2 Mammal with inducible ductal carcinoma in situ
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044886A1 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR
08/03/2000WO2000044884A1 Bhv-1 gene-deleted virus vaccine
08/03/2000WO2000044878A1 Compartmentalization of recombinant polypeptides in host cells
08/03/2000WO2000044877A1 Device for carrying out the cell-free synthesis of proteins
08/03/2000WO2000044808A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
08/03/2000WO2000044790A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000WO2000044788A1 Production of tetravalent antibodies
08/03/2000WO2000044787A1 Nucleic acid encoding bovine calcitonin receptor-like receptor
08/03/2000WO2000044786A1 Novel potassium channels and genes encoding these potassium channels
08/03/2000WO2000044783A1 Meg-4 protein
08/03/2000WO2000044782A2 Ewing's tumour antigen, nucleic acid and antibodies
08/03/2000WO2000044780A1 Polypeptide capable of binding to mannose and uses therefor
08/03/2000WO2000044777A1 Antibodies specific to kdr and uses thereof
08/03/2000WO2000044776A1 Alpha-conotoxin peptides
08/03/2000WO2000044774A2 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000WO2000044772A2 Human serum albumin
08/03/2000WO2000044766A1 Inhibition of cationic amino acid transporter protein and uses thereof
08/03/2000WO2000044759A1 Method for producing endotoxin-free nucleic acids and the use thereof
08/03/2000WO2000044497A1 Pipetter
08/03/2000WO2000044492A1 Water-insoluble linear polysaccharides for filtration
08/03/2000WO2000044438A1 Delivery of macromolecules into cells
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044406A2 Dna vaccines against hantavirus infections
08/03/2000WO2000044405A1 Dmsa promoters and derivatives thereof used for controlled expression of foreign genes
08/03/2000WO2000044403A1 Her-2 binding antagonists
08/03/2000WO2000044395A1 Methods and compositions for modulating fertility
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044391A2 Plasminogen kringle 4 region fragments and methods of use
08/03/2000WO2000044230A1 A method of controlling fungal pathogens, and agents useful for same
08/03/2000WO2000044223A1 Use of a formulation for controlling expression of a target gene
08/03/2000WO2000037614A3 Variants of egiii-like cellulase and compositions thereof
08/03/2000WO2000036095A3 FATTY ACYL-CoA: FATTY ALCOHOL ACYLTRANSFERASES
08/03/2000WO2000036081A3 Materials and methods for the modification of isoprenoid content, composition and metabolism
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000WO2000028061A3 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
08/03/2000WO2000028052A3 Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch
08/03/2000WO2000028006A3 Plant nadp-specific glutamate dehydrogenase
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000026388A3 Novel expression cassette for expressing genes in plant seed
08/03/2000WO2000026254A3 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer
08/03/2000WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases
08/03/2000WO2000024896A3 Biological material for preparing pharmaceutical compositions for treating mammals
08/03/2000WO2000024884A3 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility
08/03/2000WO2000024878A3 Mutant luciferase having increased thermostability
08/03/2000WO2000024415A3 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
08/03/2000WO2000024412A3 Use of vegf-c or vegf-d gene or protein to prevent restenosis
08/03/2000WO2000023587A3 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
08/03/2000WO2000022137A3 Selectively replicating viral vectors
08/03/2000WO2000020609A3 Protective recombinant haemophilus influenzae high molecular weight proteins
08/03/2000WO2000018964A8 Identification of virulence determinant activators in prokaryotic pathogens
08/03/2000WO2000018921A3 Synthetic peptides having fgf receptor affinity
08/03/2000WO2000017346A3 Hairpin hybridizer molecules for modulation of gene expression
08/03/2000WO2000014251A3 Human transferase proteins
08/03/2000WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers
08/03/2000WO2000012760A3 Toxicological response markers
08/03/2000WO2000009755A9 Domain specific gene evolution
08/03/2000WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
08/03/2000WO2000009689A9 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof
08/03/2000WO2000009675A9 Adenovirus formulations for gene therapy
08/03/2000WO2000009669A9 Human mesencephalon cell lines and methods of use therefor
08/03/2000WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them
08/03/2000WO2000009550A9 Vanadate resistance glycosylation 4 gene
08/03/2000WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
08/03/2000WO2000008211A3 Methods and compositions for modulating 'marginally indiscriminant' hybridizations
08/03/2000WO2000008174A9 β-CASEIN EXPRESSING CONSTRUCTS
08/03/2000WO2000008131A9 Pseudotyped retroviruses and stable cell lines for their production
08/03/2000WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof
08/03/2000WO2000007430A9 Plant fatty acid desaturase promoters
08/03/2000WO2000006731A3 Persephin arf, a protein encoded by unspliced persephin mrna
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000001823A3 Flt3-l mutants and methods of use
08/03/2000WO2000000617A9 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons
08/03/2000WO1999063975A3 A method for stimulating the immune system
08/03/2000WO1999062941A8 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/03/2000WO1999062561A3 Gene therapy method
08/03/2000WO1999059638A8 Compositions and methods for the delivery of nucleic acid molecules
08/03/2000WO1999057132A8 Secreted proteins and polynucleotides encoding them
08/03/2000WO1998017782A8 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
08/03/2000DE19950385A1 Verfahren zur Isolation von Apoptose-induzierenden DNA-Sequenzen und Detektionssystem A process for the isolation of apoptosis-inducing DNA sequences and detection system
08/03/2000DE19903495A1 Ewing-Tumor-Antigen und Nukleinsäure Ewing's tumor antigen and nucleic acid
08/03/2000DE19903493A1 Überexpression einer DNA-Sequenz codierend für eine Transketolase in Pflanzen Over-expression of a DNA sequence encoding a transketolase in plants
08/03/2000DE19903345A1 Kompartimentierung von rekombinanten Polypeptiden in Wirtszellen Compartmentalization of recombinant polypeptides in host cells
1 ... 3204 3205 3206 3207 3208 3209 3210 3211 3212 3213 3214 3215 3216 3217 3218 3219 3220 3221 3222 3223 3224 ... 4023